Chemoinformaics analysis of 6-Benzoylheteratisine
| Molecular Weight | 495.616 | nRot | 4 |
| Heavy Atom Molecular Weight | 458.32 | nRig | 33 |
| Exact Molecular Weight | 495.262 | nRing | 8 |
| Solubility: LogS | -4.441 | nHRing | 3 |
| Solubility: LogP | 3.177 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 9 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 37 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 79.0133 |
| nHD | 1 | BPOL | 45.7727 |
| QED | 0.643 |
| Synth | 6.913 |
| Natural Product Likeliness | 2.877 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.004 |
| HIA | 0.007 |
| CACO-2 | -5 |
| MDCK | 0.000066 |
| BBB | 0.742 |
| PPB | 0.52788 |
| VDSS | 1.949 |
| FU | 0.382038 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.111 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.704 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.059 |
| CYP2d6-inh | 0.227 |
| CYP2d6-sub | 0.522 |
| CYP3a4-inh | 0.456 |
| CYP3a4-sub | 0.408 |
| CL | 12.85 |
| T12 | 0.024 |
| hERG | 0.685 |
| Ames | 0.016 |
| ROA | 0.496 |
| SkinSen | 0.057 |
| Carcinogencity | 0.021 |
| EI | 0.006 |
| Respiratory | 0.896 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.881057 |